Literature DB >> 2858824

Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.

J M Lundberg, A Saria, A Franco-Cereceda, T Hökfelt, L Terenius, M Goldstein.   

Abstract

The effects of 6-hydroxydopamine (6-OHDA) and reserpine pretreatment on peripheral neuropeptide Y (NPY)- and noradrenaline (NA)-containing neurons were studied in guinea-pigs. Ten days after 6-OHDA pretreatment, a 60-80% reduction of the NA content was observed in the right atrium of the heart, stellate ganglion and spleen. The content of NPY-like immunoreactivity (LI) was reduced by about 50% in the heart, not changed in the spleen while it increased to 200% of control in the stellate ganglion. Immunohistochemistry showed a pronounced loss of NPY- and tyrosinehydroxylase (TH)-immunoreactive (IR) nerves in the heart but not in the spleen. Increased NPY-IR was seen in axons and cell bodies of the stellate ganglion. Reserpine pretreatment (thereshold dose 0.5 mg X kg-1) caused a dose- and time-dependent reduction of the content of NPY-LI in the heart. A maximal depletion of NPY-LI (about 80%) was observed 5 days after reserpine. Reserpine pretreatment also reduced the content of NPY-LI in the spleen, while no significant change was observed in the adrenal gland or vas deferens. The levels of NPY-LI increased in the stellate ganglion to about 180% of control 5 days after reserpine. Immunohistochemical analysis revealed an almost total loss of NPY-IR nerve fibres in the heart as well as around blood vessels in the lung and skeletal muscle. No detectable changes were observed in perivascular NPY-IR nerves in the spleen, vas deferens or kidney. TH-IR nerves remained unchanged after reserpine, thus indicating that the observed loss of NPY-IR nerves was due to a depletion of NPY and not a degeneration. No change in the levels of substance P-LI was observed in the right atrium 5 days after reserpine. NA was, in contrast to NPY, markedly depleted in all tissues investigated after reserpine treatment. The depletion of NA was more extensive, and occurred more rapidly and at much lower doses as compared to the effects on NPY-LI. Ligations of the sciatic nerve revealed that NPY-LI was transported axonally with a rapid rate (3 mm/h). Reserpine pretreatment significantly increased the amount of accumulated NPY-IR above the ligation, suggesting an increase in axonal transport. High performance liquid chromatography revealed that the NPY-LI consisted of two major peaks in the stellate ganglia, while only one peak closely corresponding to porcine NPY was seen in the right atrium. In conclusion, 6-OHDA pretreatment depletes NPY-LI in certain terminal regions and increases NPY-LI in ganglia.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858824     DOI: 10.1007/bf00515563

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  29 in total

1.  Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission.

Authors:  H Thoenen; R A Mueller; J Axelrod
Journal:  Nature       Date:  1969-03-29       Impact factor: 49.962

2.  Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade.

Authors:  J M Lundberg; K Tatemoto
Journal:  Acta Physiol Scand       Date:  1982-12

3.  Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves?

Authors:  S P Wilson; R L Klein; K J Chang; M S Gasparis; O H Viveros; W H Yang
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

4.  Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line.

Authors:  K A Markey; H Kondo; L Shenkman; M Goldstein
Journal:  Mol Pharmacol       Date:  1980-01       Impact factor: 4.436

5.  Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.

Authors:  J M Lundberg; L Terenius; T Hökfelt; C R Martling; K Tatemoto; V Mutt; J Polak; S Bloom; M Goldstein
Journal:  Acta Physiol Scand       Date:  1982-12

6.  Small noradrenergic storage vesicles isolated from rat vas deferens--biochemical and morphological characterization.

Authors:  G Fried
Journal:  Acta Physiol Scand Suppl       Date:  1980

7.  Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract.

Authors:  J B Furness; M Costa; P C Emson; R Håkanson; E Moghimzadeh; F Sundler; I L Taylor; R E Chance
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

8.  Localization of vasoactive intestinal polypeptide- and avian pancreatic polypeptide-like immunoreactivity in the Golgi apparatus of peripheral neurons.

Authors:  O Johansson
Journal:  Brain Res       Date:  1983-02-28       Impact factor: 3.252

9.  Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin.

Authors:  R Gamse; P Holzer; F Lembeck
Journal:  Br J Pharmacol       Date:  1980-02       Impact factor: 8.739

10.  Evidence for coexistence of vasoactive intestinal polypeptide (VIP) and acetylcholine in neurons of cat exocrine glands. Morphological, biochemical and functional studies.

Authors:  J M Lundberg
Journal:  Acta Physiol Scand Suppl       Date:  1981
View more
  27 in total

1.  A comparison of the effects of 6-hydroxydopamine and reserpine on noradrenergic and peptidergic nerves in rat brown adipose tissue.

Authors:  S Mukherjee; J D Lever; D Norman; D Symons; T L Spriggs; R T Jung
Journal:  J Anat       Date:  1989-12       Impact factor: 2.610

Review 2.  The role of neuropeptides in cardiovascular regulation.

Authors:  D Ganten; M Paul; R E Lang
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Prejunctional modulatory action of neuropeptide Y on peripheral terminals of capsaicin-sensitive sensory nerves.

Authors:  S Giuliani; C A Maggi; A Meli
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.

Authors:  R Juul; L Edvinsson; T A Fredriksen; R Ekman; A O Brubakk; S E Gisvold
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

5.  Adrenergic neurons and short proprioceptive feedback loops involved in the integration of cardiac function in the rat.

Authors:  M Moravec; J Moravec
Journal:  Cell Tissue Res       Date:  1989-11       Impact factor: 5.249

6.  Distribution and origin of substance P- and neuropeptide Y-immunoreactive nerves in the guinea-pig heart.

Authors:  C J Dalsgaard; A Franco-Cereceda; A Saria; J M Lundberg; E Theodorsson-Norheim; T Hökfelt
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

7.  Reserpine-induced immunocytochemical change of neuropeptide Y in the hypothalamic arcuate nucleus.

Authors:  H Okamura; T Sugano; Y Ibata
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

8.  Neuropeptide Y immunoreactivity in the mammalian liver: pattern of innervation and coexistence with tyrosine hydroxylase immunoreactivity.

Authors:  L E Goehler; C Sternini
Journal:  Cell Tissue Res       Date:  1991-08       Impact factor: 5.249

9.  Neuropeptide Y: intrapancreatic neuronal localization and effects on insulin secretion in the mouse.

Authors:  M Pettersson; B Ahrén; I Lundquist; G Böttcher; F Sundler
Journal:  Cell Tissue Res       Date:  1987-04       Impact factor: 5.249

10.  Neuropeptide Y and reserpine-resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle.

Authors:  J Pernow; T Kahan; J M Lundberg
Journal:  Br J Pharmacol       Date:  1988-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.